Number: RL34102
Title: FDA Legislation in the 110th Congress: A Side-by-Side Comparison of S. 1082 and H.R. 2900
Authors: Erin D. Williams, Susan Thaul, Sarah A. Lister, Donna V. Porter, and C. Stephen Redhead, Domestic Social Policy Division 
Abstract: This report presents a side-by-side analysis of S. 1082 and H.R. 2900, highlighting the differences between the bills. It contains individual tables on topics covered by the bills, including prescription drug user fees, medical device user fees, medical device regulation, pediatric exclusivity incentives (BPCA), mandatory pediatric assessments (PREA), pediatric medical devices, drug safety, antibiotic drugs, clinical trials databases, conflicts of interest, importation of prescription drugs, a new Reagan-Udall Foundation, food safety, domestic pet turtle market access, and other provisions. In general, provisions in the two bills amend FDA's authorities in the Federal Food, Drug and Cosmetic Act (FFDCA) or the Public Health Service Act (PHSA).
Pages: 63
Date: August 6, 2007